Artificial intelligence chatbots are standardizing how people speak, write and think. If this homogenization continues ...
If you want to start a fight at nearly any meeting or party in Hollywood, all you have to is suggest that Netflix’s ...
In Chicago, apartment rental platform Domu recently launched a campaign that places local influencers directly onto CTA buses and shelters — effectively turning creators into walking billboards for ...
Despite significant mathematical refinements, econometrics has shown the weaknesses of its logical underpinnings, primarily during economic turning points—financial crises, pandemics, and geopolitical ...
Background Double-checking of medication administration is a safety practice used in hospitals around the world. Independence is recommended as the key to effectiveness. Independent double-checking ...
Campaign Middle East on MSN
Luma AI’s Jason Day on how agentic AI is remaking the creative process of marketing
Agentic AI is remaking the strategic and creative process within marketing from the inside out. This is not a ‘nice-to-have’ ...
In most boardrooms, the final decision still comes down to a small circle of leaders weighing a narrow set of choices. Yet the problems they face now contain thousands, sometimes millions, of possible ...
G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...
For Andrew Hall, a veteran of Big Pharma-turned biotech builder, he has spent much of his recent career operating inside those constraints — and learning how to lead through them. Today, as CEO of ...
Five years ago, the IT behemoth was untouchable. Now it faces major challenges to its business model from the rise of the new technology.
This is an audio transcript of The Economics Show podcast episode: ‘Is AI (finally) making us more productive? With John Burn-Murdoch and Sarah O’Connor’ Soumaya Keynes I have read a lot of science ...
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results